Pall Corporation Introduces Proprietary Bioreactor Control System

Thursday, July 27, 2017 Corporate News
Email Print This Page Comment bookmark
Font : A-A+

PORT WASHINGTON, N.Y., July 27, 2017 /PRNewswire/ -- Pall Corporation, a leader in filtration, separation and purification,

is pleased to introduce the mPath™ bioreactor control system to the biopharmaceutical market. The mPath benchtop bioreactor control system is a first-of-its-kind solution to deliver accurate measurement and control of single-use process development-scale
bioprocesses. It will support the Allegro™ XRS 25 bioreactor, with further expansions planned for the mPath portfolio in 2017 and beyond.

"Throughout the development of the mPath bioreactor control system, our team was focused on simplifying single-use lab-scale bioprocesses with a functional, integrated user experience," explained Loe Cameron, Director of Analytics and Controls at Pall. "The architecture makes plug-and-play connectivity a reality, while providing access to features of Pall bioreactors that other commercial control options do not allow. Additionally, the mPath bioreactor control system has been designed to support characterization and optimization and is compliant with cGMP regulations."

An expandable control and data management system includes both bioreactor control towers and an advanced supervisory control and data acquisition (SCADA) software package. The mPath control tower is cleanroom-ready after being IP54 designed and tested, and comes with features such as six (6) mass flow controllers (MFCs) as standard. There are three (3) variable speed pumps for feeds, titrants and media fills, and three (3) biocontainer hangers with integrated load cells to organize and weigh titrants, feeds and media with a minimal footprint. All of this comes at no additional cost to buyers, and there are no limits on the number of systems or users that can run the control software.

"At Pall, we remain driven to advance the biopharmaceutical industry by delivering innovative total solutions to end users," said Martin Smith, Chief Technology Officer at Pall. "The launch of the mPath bioreactor control system represents the first in our next generation of unifying technologies for a seamless, fully controlled, and value-based user experience."

To learn more about the mPath control system or to speak with a Pall Life Sciences representative, please visit: or email

Find the Pall Life Sciences biopharmaceutical division on social media here:

LinkedIn – Twitter – YouTube

About Pall CorporationPall Corporation is a filtration, separation and purification leader providing solutions to meet the critical fluid management needs of customers across the broad spectrum of life sciences and industry. Pall works with customers to advance health, safety and environmentally responsible technologies. The company's engineered products enable process and product innovation and minimize emissions and waste. Pall Corporation serves customers worldwide.

For more information visit  

Or follow us on social media: Google+ - YouTube -   LinkedIn - Twitter - Facebook

Corporate Media ContactPall Corporation Mariann KourafasDirector of Communications+1-508-871-5469

Media ContactWhite Matter CommunicationsBeth Willers  +1-415-905-0324

View original content:

SOURCE Pall Corporation

Post your Comments

Comments should be on the topic and should not be abusive. The editorial team reserves the right to review and moderate the comments posted on the site.
* Your comment can be maximum of 2500 characters
I agree to the terms and conditions

News A - Z


News Search

Medindia Newsletters

Subscribe to our Free Newsletters!

Terms & Conditions and Privacy Policy.

Find a Doctor

Press Release Category

Press Release Archive

Stay Connected

  • Available on the Android Market
  • Available on the App Store